Humancare Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 27-12-2024
- Paid Up Capital ₹ 0.10 M
as on 27-12-2024
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.60 M
as on 27-12-2024
- Satisfied Charges ₹ 2.50 M
as on 27-12-2024
- Revenue %
(FY 2022)
- Profit -322.13%
(FY 2022)
- Ebitda -1873.64%
(FY 2022)
- Net Worth -153.69%
(FY 2022)
- Total Assets -68.78%
(FY 2022)
About Humancare Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.60 M. The company has closed loans amounting to ₹2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Rameshwar Abhisek and Ratnesh Kumar serve as directors at the Company.
- CIN/LLPIN
U24230BR2005PTC011594
- Company No.
011594
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Sep 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- LocationUr Cantt Road Khagual Patna, Bihar
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Humancare Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rameshwar Abhisek  | Director | 05-Sep-2005 | Current |
| Ratnesh Kumar | Additional Director | 02-Nov-2021 | Current |
Financial Performance of Humancare Pharma.
Humancare Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 322.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 153.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Humancare Pharma?
In 2022, Humancare Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 28 Mar 2007 | ₹0.60 M | Open |
Canara Bank Creation Date: 28 Mar 2007 | ₹2.50 M | Satisfied |
How Many Employees Work at Humancare Pharma?
Unlock and access historical data on people associated with Humancare Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Humancare Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Humancare Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
